Invention Application
US20140378421A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
有权
具有β2ADRENERGIC AGONIST和M3 MUSCARINIC ANTAGONIST活动的新CYCLOHEXYLAMINE衍生物
- Patent Title: NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
- Patent Title (中): 具有β2ADRENERGIC AGONIST和M3 MUSCARINIC ANTAGONIST活动的新CYCLOHEXYLAMINE衍生物
-
Application No.: US14357344Application Date: 2012-11-09
-
Publication No.: US20140378421A1Publication Date: 2014-12-25
- Inventor: Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
- Applicant: ALMIRALL, S.A.
- Priority: EP11382344.7 20111111
- International Application: PCT/EP2012/072309 WO 20121109
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K45/06 ; C07D401/12 ; C07D409/12 ; C07D413/14 ; A61K31/428 ; A61K31/4178 ; C07D263/58 ; A61K31/423 ; A61K31/538 ; C07D417/14 ; C07D413/12 ; C07D417/12
Abstract:
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Public/Granted literature
- US09233108B2 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities Public/Granted day:2016-01-12
Information query
IPC分类:
